Skip to main content
. Author manuscript; available in PMC: 2008 Dec 18.
Published in final edited form as: J Cereb Blood Flow Metab. 2007 Jul 18;28(2):329–340. doi: 10.1038/sj.jcbfm.9600527

Figure 2.

Figure 2

Evaluation of the ischemic lesion volume with DWIs and T2WIs. Human mesenchymal stem cells or Ang-hMSCs were intravenously injected immediately after the initial MRI scanning (6 h after MCAO). Diffusion-weighted image obtained 6 h MCAO in medium-injected (A-1), hMSC-treated (A-2), and Ang-hMSC-treated group (A-3). T2-weighted images obtained 6 h, 1, 3, and 7 days MCAO in medium-injected (B-1-1 to -4), hMSC-treated (B-2-1 to -4), and Ang-hMSC-treated group (B-3-1 to -4). Bar=5 mm. (C) A summary of lesion volumes evaluated with MRI (T2WI) were obtained 6 h, 1, 3, and 7 days after MCAO in rats treated with medium (control), hMSC, or Ang-hMSC.